Guideline for the diagnosis and management of hyperuricemia and gout in China(2019)
中国高尿酸血症与痛风诊疗指南(2019)(43292)
The ACE trial: a new perspective on the effect of acarbose on cardiovascular outcomes
ACE研究:阿卡波糖对心血管结局影响的新视角(33723)
Implications and challenges of the ACE trial
ACE研究的启示和挑战(30276)
Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
中国甲状腺功能亢进症和其他原因所致甲状腺毒症诊治指南(27351)
Value of individualized, patient-centered use of short-acting glucagon-like peptide-1 receptor agonist lixisenatide for the treatment of type 2 diabetes mellitus
短效胰升糖素样肽1受体激动剂利司那肽在2型糖尿病个体化治疗中的价值(26191)
Individualized, patient-centered use of lixisenatide for the treatment of type 2 diabetes mellitus
利司那肽在2型糖尿病个体化治疗中的应用(25655)
All the human researches, including clinical trials, should follow with the standards of Good Clinical Practice and Helsinki Declaration, and with all applicable regulatory requirements. This basic principle of medical ethics is applicable to the whole process of the clinical studies, from designing, conducting, monitoring, auditing, recording, analyzing, and reporting the results. It is also utmost important to ensure that personal information, privacy, rights, safety and wellbeing of the study participants are protected.
Animals possess their own lives and their basic rights, including but not limited to avoiding suffering, thus animals’ rights should be considered and afforded similarly as human beings.
When submitting the manuscript, the author must declare whether the research procedure used has complied with the ethical codes established by the committee for human research studies (of relevant unit, region or nation). The author must provide the approval from the relevant committee (the approval code must be stated in the article), and the informed consent agreement form signed by the test subject or family member must be provided on demand.